The global Bioprocess Containers Market is witnessing significant growth as pharmaceutical and biopharmaceutical manufacturers increasingly adopt single-use technologies to improve production efficiency, reduce contamination risks, and support the growing demand for biologics. According to recent industry analysis, the global market was valued at USD 4.98 billion in 2025 and is projected to grow from USD 5.92 billion in 2026 to USD 23.95 billion by 2034, registering a CAGR of 19.09% during the forecast period.
Bioprocess containers, including 2D and 3D single-use bags, play a vital role in upstream processing, downstream purification, storage, and transportation of critical biopharmaceutical materials. These systems are widely used in monoclonal antibody manufacturing, vaccine production, cell and gene therapies, and biosimilar development.
The increasing preference for disposable technologies over traditional stainless-steel systems is driving strong market demand. Single-use containers eliminate complex cleaning validation procedures, reduce operational downtime, and improve manufacturing flexibility, making them ideal for modern biologics facilities and contract manufacturing organizations.
Rising Adoption of Single-Use Technologies Boosts Industry Growth
Expansion of Biologics Manufacturing Facilities Creates Strong Demand
The rapid expansion of biologics manufacturing facilities across North America, Europe, and Asia Pacific is a major factor contributing to market growth. More than 65% of newly commissioned biologics manufacturing lines globally are now based on single-use technologies. Pharmaceutical companies and CDMOs are increasingly deploying disposable bioprocess systems to accelerate production timelines and reduce capital investments.
The growing production of monoclonal antibodies, mRNA vaccines, viral vectors, and CAR-T therapies is further strengthening demand for high-performance bioprocess containers capable of maintaining sterility and product integrity throughout manufacturing processes.
In addition, manufacturers are increasingly investing in modular and continuous bioprocessing facilities that rely heavily on integrated disposable systems. These facilities offer faster deployment timelines and greater scalability, especially for emerging biologics markets.
Advanced Film Technologies Supporting Sensitive Biologics Production
High-Barrier Films Improve Stability of mRNA and Cell Therapies
Manufacturers are introducing advanced multilayer fluoropolymer and ethylene-vinyl alcohol films to support highly sensitive biologics such as mRNA vaccines and cell therapies. These next-generation materials significantly reduce oxygen permeability and minimize extractables and leachables, improving product stability during storage and transportation.
Companies are also developing cryogenic-compatible single-use containers designed for ultra-low temperature applications ranging from -70°C to -196°C. These innovations are becoming increasingly important as global demand for cell and gene therapies continues to rise.
Furthermore, automated closed-loop single-use assemblies are gaining traction in continuous bioprocessing applications. These systems integrate tubing, connectors, and bioprocess bags into sterile fluid handling networks, reducing contamination risks and improving operational efficiency.
Environmental and Regulatory Challenges Remain Key Concerns
Disposal of Single-Use Plastic Waste Continues to Challenge Manufacturers
Despite strong market momentum, environmental sustainability remains a major challenge for the industry. Single-use bioprocess systems generate significant volumes of plastic waste from bags, tubing, and connectors. Since many of these materials are gamma-sterilized multilayer polymers, recycling remains difficult.
Biopharmaceutical manufacturers are increasingly facing pressure from regulatory authorities and sustainability initiatives to minimize waste generation and improve disposal processes. This is encouraging suppliers to explore bio-circular materials and environmentally sustainable alternatives.
Regulatory compliance associated with extractables and leachables testing also continues to increase operational complexity. Validation requirements for single-use systems can extend product qualification timelines and increase development costs for biopharmaceutical companies.
North America Maintains Market Leadership While Asia Pacific Emerges as Fastest-Growing Region
Strong CDMO Presence and Biologics Investments Support Regional Expansion
North America accounted for the largest share of the global bioprocess containers market in 2025, representing 31.57% of total revenue. The region benefits from a strong concentration of biologics manufacturing facilities, advanced CDMO infrastructure, and increasing investment in mRNA and cell therapy production.
The United States continues to lead regional growth due to expanding cell and gene therapy clinical trials, strong FDA support for advanced therapeutics, and rising investment in flexible biomanufacturing facilities.
Meanwhile, Asia Pacific is projected to register the fastest growth during the forecast period with a CAGR of 21.73%. Countries such as China, India, South Korea, and Singapore are rapidly expanding biologics manufacturing capacity through government-backed initiatives and growing CDMO ecosystems.
Increasing biosimilar production, rising vaccine manufacturing, and expansion of GMP-certified facilities are accelerating adoption of disposable bioprocessing technologies across the region.
Key Players Focus on Innovation and Strategic Expansion
Leading Companies Strengthen Product Portfolios Through Innovation
The bioprocess containers market remains moderately consolidated, with leading companies focusing on innovation, acquisitions, and strategic partnerships to strengthen their market positions.
Key players operating in the market include:
Thermo Fisher Scientific Inc.
Sartorius AG
Merck KGaA
Danaher
Saint-Gobain
Avantor Inc.
Lonza Group
Corning Incorporated
Parker Hannifin Corporation
Entegris Inc.
Meissner Filtration Products
Repligen Corporation
Eppendorf SE
Getinge AB
GE HealthCare
Recent industry developments include Sartorius AG expanding bio-circular materials across its single-use portfolio and Thermo Fisher Scientific strengthening its biopharma services capabilities through strategic acquisitions.
Gain access to expanded insights on competitive strategies, market size, and regional analysis. View our Market Report Overview here: https://straitsresearch.com/report/bioprocess-containers-market
About Straits Research
Straits Research is a leading market research and intelligence company providing global business insights, analytics, and advisory services. The company delivers comprehensive market reports across healthcare, biotechnology, chemicals, ICT, energy, and advanced manufacturing industries. Straits Research helps organizations make informed strategic decisions through accurate data analysis, emerging trend evaluation, and competitive intelligence solutions tailored to evolving industry requirements.
Top comments (0)